Loading…

Magnetic Resonance Imaging Biomarker of Axon Loss Reflects Cervical Spondylotic Myelopathy Severity

STUDY DESIGN.A prospective cohort study. OBJECTIVE.In this study, we employed diffusion basis spectrum imaging (DBSI) to quantitatively assess axon/myelin injury, cellular inflammation, and axonal loss of cervical spondylotic myelopathy (CSM) spinal cords. SUMMARY OF BACKGROUND DATA.A major shortcom...

Full description

Saved in:
Bibliographic Details
Published in:Spine (Philadelphia, Pa. 1976) Pa. 1976), 2016-05, Vol.41 (9), p.751-756
Main Authors: Murphy, Rory K J, Sun, Peng, Xu, Junqian, Wang, Yong, Sullivan, Samir, Gamble, Paul, Wagner, Joanne, Wright, Neill N, Dorward, Ian G, Riew, Daniel, Santiago, Paul, Kelly, Michael P, Trinkaus, Kathryn, Ray, Wilson Z, Song, Sheng-Kwei
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:STUDY DESIGN.A prospective cohort study. OBJECTIVE.In this study, we employed diffusion basis spectrum imaging (DBSI) to quantitatively assess axon/myelin injury, cellular inflammation, and axonal loss of cervical spondylotic myelopathy (CSM) spinal cords. SUMMARY OF BACKGROUND DATA.A major shortcoming in the management of CSM is the lack of an effective diagnostic approach to stratify treatments and to predict outcomes. No current clinical diagnostic imaging approach is capable of accurately reflecting underlying spinal cord pathologies. METHODS.Seven patients with mild (mJOA ≥15), five patients with moderate (14≥mJOA ≥11), and two patients with severe (mJOA
ISSN:0362-2436
1528-1159
DOI:10.1097/BRS.0000000000001337